Quantcast

Latest Nora Therapeutics Inc. Stories

2014-05-28 12:31:48

PALO ALTO, Calif., May 28, 2014 /PRNewswire/ -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today that CEO Jeffrey K. Tong, Ph.D., is scheduled to participate in the following conferences in June: -- Jefferies 2014 Global Healthcare Conference on Monday, June 2, 2014 at 10:00 a.m. EDT in New York City, NY. -- Boston CEO Conference on Wednesday, June 4, 2014 at 11:15 a.m. EDT in...

2014-04-17 08:27:42

To support continued development of NT100, including addition of Ph2 RESPONSE trial in recurrent pregnancy loss indication PALO ALTO, Calif., April 17, 2014 /PRNewswire/ -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, today announced the closing of an $18 million Series B financing. The proceeds will be used to expand the development of Nora's lead drug, NT100, including the addition of a second Phase...

2014-03-27 08:34:38

PALO ALTO, Calif., March 27, 2014 /PRNewswire/ -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, today announced that Dennis M. Fenton, Ph.D. has been elected to the company's board of directors. Dr. Fenton is a recognized pioneer in the biopharmaceutical industry, and retired from Amgen in 2008 as its Executive Vice President of Operations. During his 25-year tenure at Amgen, he had executive...

2014-03-21 08:24:59

PALO ALTO, Calif., March 21, 2014 /PRNewswire/ -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today that CEO Jeffrey K. Tong, Ph.D., is scheduled to present at the 21(st) Annual Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel in New York City on Friday, March 28, 2014 at 3:20 p.m. EDT. About Nora Therapeutics, Inc. Nora Therapeutics is a privately-held...

2014-03-04 08:31:59

PALO ALTO, Calif., March 4, 2014 /PRNewswire/ -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today that CEO Jeffrey K. Tong, Ph.D., is scheduled to present at the 26(th) Annual ROTH Conference at the Ritz-Carlton in Laguna Niguel, CA, on Monday, March 10, 2014 at 4:15 p.m. PDT. About Nora Therapeutics, Inc. Nora Therapeutics is a privately-held biotechnology company focused on developing...

2014-02-05 08:29:32

PALO ALTO, Calif., Feb. 5, 2014 /PRNewswire/ -- Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today that CEO Jeffrey K. Tong, Ph.D., is scheduled to present at the following conferences in February: -- 16(th) Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York on Tuesday, Feb. 11, 2014 at 8:45 a.m. (EST). -- Leerink Global Healthcare Conference 2014 at the...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related